MedPath
NMPA Approval

Oseltamivir Phosphate for Suspension

国药准字H20244903

September 19, 2024

Drug Information

磷酸奥司他韦干混悬剂

口服混悬剂

0.36g(按C₁₆H₂₈N₂O₄计)

化学药品

September 19, 2024

Company Information

Applicant Company

重庆市北碚区水土镇方正大道21号

Manufacturing Company

山东省德州市齐河县晏北街道办事处齐众大道127号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸奥司他韦干混悬剂 - NMPA 批准文号 | MedPath